Larvol Delta - Effect-of-ibrutinib-on-CCR7-expression-and-functionality-in-chronic-lymphocytic-leukemia-and-its-implication-for-the-activity-of-CAP100-a-novel-therapeutic-antiCCR7-antibody

ibrutinib - Generic mfg.

CAP-100 - Catapult Therap

http://www.ncbi.nlm.nih.gov/pubmed/34297159

Jul 28, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next